The Natural Path - Women's Formula
Natural health product licensed in Canada
If this product were sold in France
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Citrate de zinc | 2.5 mg | Not calculated |
| Biotine Source : Biotine | 25 mcg | Not calculated |
| Protéines de pois Source : Pisum sativum - Graine Potency : 80 % Protein | 16.25 g | Not calculated |
| Chlorella vulgaris Source : Cellule brisée | 100 mg | Not calculated |
| Lycium barbarum Source : Fruit | 150 mg | Not calculated |
| Medicago sativa Source : Sommité Extraction ratio : 4:1 Dry plant equivalent : 500 mg | 125 mg | Not calculated |
| Bêta-carotène Source : bêta-carotène Potency : 500 UI | 300 mcg | Not calculated |
| Petroselinum crispum Source : Feuille | 650 mg | Not calculated |
| Calcium Source : Citrate de calcium | 300 mg | Not calculated |
| Vitamine K1 Source : Vitamine K1 | 120 mcg | Not calculated |
| Protéine de riz Source : Oryza sativa - Graine Potency : 80 % Protein | 6.25 g | Not calculated |
| Vitamine C Source : Vitamine C | 50 mg | Not calculated |
| Sélénium Source : Levure au sélénium | 25 mcg | Not calculated |
| Prunus avium Source : Fruit | 250 mg | Not calculated |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle Potency : 25 UI | 16.74 mg AT | Not calculated |
| Acide d-pantothénique Source : D-Pantothénate de calcium | 12.5 mg | Not calculated |
| Cinnamomum aromaticum Source : Écorce (branche) Extraction ratio : 4:1 Dry plant equivalent : 3,000 mg | 750 mg | Not calculated |
| Cuivre Source : Citrate cuivrique | 250 mcg | Not calculated |
| Vanadium Source : Sulfate de vanadyle | 7.5 mcg | Not calculated |
| Molybdène Source : Molybdate de sodium (VI) dihydraté | 7.5 mcg | Not calculated |
Non-medicinal ingredients
Gomme de Guar, Poudre de cacao, Feuille de Stevia rebaudiana, Xylitol, Saveur de thé vert, Saveur de chocolat, Saveur de vanille
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Mesures | 1 day |
Uses authorised in Canada
Multi-vitamin and multi-mineral supplement. A factor in the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. A source of antioxidant for the maintenance of good health. A source of protein for the maintenance of good health. Used in Herbal Medicine to help prevent (recurrent) urinary tract infections (UTIs) and (Used in Herbal Medicine to) help(s) prevent recurrent urinary tract infections (UTIs) in women. Helps to support healthy blood glucose levels. Adequate calcium (and vitamin D) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- Chocolate Flavour Nutritional Shake for Women
- Licence holder
- Orange Naturals
- NPN or DIN-HM
- 80044941
- Status
- Inactive licence
- Licence date
- 24 September 2013
- Revision date
- Not provided
- Form
- Poudre pour suspension
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80044941
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Chlorella vulgaris
Read the warning, when it applies and the studies cited
CHLORELLA - CHLORELLA VULGARIS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Applies to products providing 250 mg or more of chlorella per day or 6 µg or more vitamin K per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Ohkawa et al. 1995; NNHPD Multi-vitamin/mineral supplements monograph).
Sources cited by Health Canada (1)
- Ohkawa S, Yoneda Y, Ohsumi Y, Tabuchi M. Warfarin therapy and chlorella. Rinsho Shinkeigaku 1995;35(7):806-807. PubMed Case report
Applies to products containing chlorella enriched with selenium and providing more than 70 µg of selenium per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of non-melanoma skin cancer (Doucha et al. 2009; NNHPD Multi-vitamin/mineral supplements monograph).
Sources cited by Health Canada (1)
- Doucha J, Livansky K, Kotrbacek V, Zachleder V. Production of Chlorella biomass enriched by selenium and its use in animal nutrition: a review. Applied Microbiology and Biotechnology 2009;83(6):1001-1008. PubMed Review article
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Tiberg et al. 1995).
Sources cited by Health Canada (1)
- Tiberg E, Dreborg S, Bjorksten B. Allergy to green algae (Chlorella) among children. Journal of Allergy and Clinical Immunology 1995;96(2):257-259. PubMed
- Medicago sativa
Read the warning, when it applies and the studies cited
ALFALFA - MEDICAGO SATIVA
Route of administration: Oral
Cautions and warnings
Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners, birth control medication or hormone therapy (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Condition of application: All products.
Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.
Do not use if you have a history of systemic lupus erythematosus (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.